108 related articles for article (PubMed ID: 1423763)
1. Lignified materials as medicinal resources. V. Anti-HIV (human immunodeficiency virus) activity of some synthetic lignins.
Nakashima H; Murakami T; Yamamoto N; Naoe T; Kawazoe Y; Konno K; Sakagami H
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2102-5. PubMed ID: 1423763
[TBL] [Abstract][Full Text] [Related]
2. Lignified materials as medicinal resources. VI. Anti-HIV activity of dehydrogenation polymer of p-coumaric acid, a synthetic lignin, in a quasi-in-vivo assay system as an intermediary step to clinical trials.
Shimizu N; Naoe T; Kawazoe Y; Sakagami H; Nakashima H; Murakami T; Yamamoto N
Biol Pharm Bull; 1993 Apr; 16(4):434-6. PubMed ID: 8358397
[TBL] [Abstract][Full Text] [Related]
3. Effect of lignins on HIV-induced cytopathogenicity and myeloperoxidase activity in human myelogenous leukemic cell lines.
Kunisada T; Sakagami H; Takeda M; Naoe T; Kawazoe Y; Ushijima H; Müller WE; Kitamura T
Anticancer Res; 1992; 12(6B):2225-8. PubMed ID: 1338279
[TBL] [Abstract][Full Text] [Related]
4. Unusual single-stranded polyribonucleotides as potent anti-HIV agents.
Broom AD; Agrawal VK; Tutonda MG; Fain HD; Buckheit RW
J Med Chem; 1995 Aug; 38(17):3253-7. PubMed ID: 7650678
[TBL] [Abstract][Full Text] [Related]
5. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
Nakashima H; Masuda M; Murakami T; Koyanagi Y; Matsumoto A; Fujii N; Yamamoto N
Antimicrob Agents Chemother; 1992 Jun; 36(6):1249-55. PubMed ID: 1384424
[TBL] [Abstract][Full Text] [Related]
6. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.
Baba M; Schols D; De Clercq E; Pauwels R; Nagy M; Györgyi-Edelényi J; Löw M; Görög S
Antimicrob Agents Chemother; 1990 Jan; 34(1):134-8. PubMed ID: 2327749
[TBL] [Abstract][Full Text] [Related]
7. Antitumor, antiviral and immunopotentiating activities of pine cone extracts: potential medicinal efficacy of natural and synthetic lignin-related materials (review).
Sakagami H; Kawazoe Y; Komatsu N; Simpson A; Nonoyama M; Konno K; Yoshida T; Kuroiwa Y; Tanuma S
Anticancer Res; 1991; 11(2):881-8. PubMed ID: 1648335
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase.
Inouye Y; Tokutake Y; Kunihara J; Yoshida T; Yamase T; Nakata A; Nakamura S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):805-7. PubMed ID: 1377101
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
10. Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2.
Manfredi KP; Blunt JW; Cardellina JH; McMahon JB; Pannell LL; Cragg GM; Boyd MR
J Med Chem; 1991 Dec; 34(12):3402-5. PubMed ID: 1766007
[No Abstract] [Full Text] [Related]
11. In vitro assessment of compounds for anti-HIV activity.
Patience C; Moore J; Boyd M
Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
[TBL] [Abstract][Full Text] [Related]
12. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells.
Lemaître M; Guétard D; Hénin Y; Montagnier L; Zerial A
Res Virol; 1990; 141(1):5-16. PubMed ID: 2326552
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics.
Balzarini J; Pannecouque C; De Clercq E; Pavlov AY; Printsevskaya SS; Miroshnikova OV; Reznikova MI; Preobrazhenskaya MN
J Med Chem; 2003 Jun; 46(13):2755-64. PubMed ID: 12801238
[TBL] [Abstract][Full Text] [Related]
14. Anti-influenza virus activity of synthetically polymerized phenylpropenoids.
Sakagami H; Nagata K; Ishihama A; Oh-hara T; Kawazoe Y
Biochem Biophys Res Commun; 1990 Nov; 172(3):1267-72. PubMed ID: 2244910
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of human immunodeficiency virus by MDL 101028, a novel sulphonic acid polymer.
Taylor DL; Brennan TM; Bridges CG; Mullins MJ; Tyms AS; Jackson R; Cardin AD
Antiviral Res; 1995 Oct; 28(2):159-73. PubMed ID: 8585769
[TBL] [Abstract][Full Text] [Related]
16. Antiviral properties of a mangrove plant, Rhizophora apiculata Blume, against human immunodeficiency virus.
Premanathan M; Arakaki R; Izumi H; Kathiresan K; Nakano M; Yamamoto N; Nakashima H
Antiviral Res; 1999 Dec; 44(2):113-22. PubMed ID: 10669261
[TBL] [Abstract][Full Text] [Related]
17. 2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.
Artico M; Silvestri R; Massa S; Loi AG; Corrias S; Piras G; La Colla P
J Med Chem; 1996 Jan; 39(2):522-30. PubMed ID: 8558522
[TBL] [Abstract][Full Text] [Related]
18. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound.
Chanh TC; Lewis DE; Allan JS; Sogandares-Bernal F; Judy MM; Utecht RE; Matthews JL
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):891-6. PubMed ID: 8257636
[TBL] [Abstract][Full Text] [Related]
20. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
